Impact of proteasome inhibitor vs. IMiD maintenance therapy on outcomes of patients with high-risk multiple myeloma (HRMM).

被引：0
|
作者：
Tam, Eric Leon
Iberri, David Joseph
Liedtke, Michaela
Muffly, Lori S.
Shiraz, Parveen
Frank, Matthew Joshua
Lowsky, Robert
Rezvani, Andrew
Negrin, Robert
Meyer, Everett
Arai, Sally
Johnston, Laura J.
Shizuru, Judith
Weng, Wen-Kai
Miklos, David Bernard
Sidana, Surbhi
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Stanford, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20557
引用
收藏
页数：2
相关论文
共 50 条
  • [21] High-Risk Multiple Myeloma: Different Definitions, Different Outcomes?
    Paszekova, Helena
    Kryukov, Fedor
    Kubiczkova, Lenka
    Hajek, Roman
    Sevcikova, Sabina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (01): : 24 - 30
  • [22] Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone
    H Avet-Loiseau
    J Soulier
    J-P Fermand
    I Yakoub-Agha
    M Attal
    C Hulin
    L Garderet
    K Belhadj
    V Dorvaux
    S Minvielle
    P Moreau
    Leukemia, 2010, 24 : 623 - 628
  • [23] Crowdsourcing a High-Risk Classifier for Multiple Myeloma Patients
    Dervan, Andrew P.
    Mason, Michael
    Towfic, Fadi
    Amatangelo, Michael
    Auclair, Daniel
    Bassett, Douglas
    Dai, Hongyue
    Dalton, William S.
    Danziger, Samuel
    Flynt, Erin
    Goldschmidt, Hartmut
    Guinney, Justin
    Hose, Dirk
    Mavrommatis, Konstantimos
    Morgan, Gareth J.
    Munshi, Nikhil
    Ratushny, Alexander
    Rozelle, Dan
    Samur, Mehmet Kemal
    Schmitz, Frank
    Shain, Kenneth H.
    Trotter, Matthew
    Walker, Brian A.
    White, Brian S.
    Yu, Thomas
    Thakurta, Anjan
    BLOOD, 2017, 130
  • [24] Use of Doublet Maintenance (Bortezomib-Lenalidomide) Vs Monotherapy Lenalidomide As Maintenance Therapy Post-Transplant of Patients with High-Risk Cytogenetics Myeloma
    Laharwal, Mehak M.
    Snyder, Jordan
    Khaliq, Aroog
    Rahman, Raeef L.
    Atrash, Shebli
    Mushtaq, Muhammad Umair
    Abdallah, Al-Ola
    Ahmed, Nausheen
    Mewawalla, Prerna
    BLOOD, 2024, 144 : 7017 - 7018
  • [25] Distinct predictive impact of FISH abnormality in proteasome inhibitors and immunomodulatory agents response: redefining high-risk multiple myeloma in Asian patients
    Byun, Ja Min
    Shin, Dong-Yeop
    Hong, Junshik
    Kim, Inho
    Kim, Hyun Kyung
    Lee, Dong Soon
    Koh, Youngil
    Yoon, Sung-Soo
    CANCER MEDICINE, 2018, 7 (03): : 831 - 841
  • [26] Early Therapy Benefits High-Risk Smoldering Multiple Myeloma
    不详
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (11) : E1 - E1
  • [27] Analysis of Real-World Data on Overall Survival in Multiple Myeloma Patients With ≥3 Prior Lines of Therapy Including a Proteasome Inhibitor (PI) and an Immunomodulatory Drug (IMiD), or Double Refractory to a PI and an IMiD
    Usmani, Saad
    Ahmadi, Tahamtan
    Ng, Yvette
    Lam, Annette
    Desai, Avinash
    Potluri, Ravi
    Mehra, Maneesha
    ONCOLOGIST, 2016, 21 (11): : 1355 - 1361
  • [28] Outcomes of Bortezomib Maintenance Compared with Lenalidomide Maintenance in Patients with High-Risk Multiple Myeloma and Chronic Kidney Disease Undergoing Autologous Stem Cell Transplant
    Nangia, Udit
    Chandramohan, Deepak
    Garapati, Hari Naga
    Simhadri, Prathap
    Mahajan, Neeraj
    BLOOD, 2024, 144 : 4754 - 4754
  • [29] Impact of Ultra High-risk Genetics on Real-world Outcomes of Transplant-eligible Multiple Myeloma Patients
    Panopoulou, Aikaterini
    Easdale, Sandra
    Ethell, Mark
    Nicholson, Emma
    Potter, Mike
    Giotas, Asterios
    Woods, Helena
    Thornton, Tracy
    Pawlyn, Charlotte
    Boyd, Kevin D.
    Kaiser, Martin F.
    HEMASPHERE, 2023, 7 (02): : E831
  • [30] Biomarkers of Cardiotoxicity Among Multiple Myeloma Patients Subsequently Treated with Proteasome Inhibitor Therapy
    Lendvai, Nikoletta
    Devlin, Sean
    Patel, Minal
    Knapp, Kristina Marie
    Ekman, Daniel
    Grundberg, Ida
    Chung, David J.
    Hassoun, Hani
    Koehne, Guenther
    Lesokhin, Alexander M.
    Landau, Heather
    Giralt, Sergio A.
    Korde, Neha S.
    Landgren, Ola
    BLOOD, 2015, 126 (23)
12345